Keyphrases
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
100%
Cytoreductive Surgery
93%
Adjuvant Chemotherapy
38%
Colorectal Cancer
36%
Overall Survival
35%
Peritoneal Cancer Index
34%
Metastatic Colorectal Cancer (mCRC)
33%
Colorectal Metastases
29%
Elderly Patients
29%
Breast Cancer Susceptibility Gene 1 (BRCA1)
27%
Oncological Outcomes
24%
Pathological Stage
24%
Secondary Cytoreductive Surgery
23%
Colorectal Peritoneal Metastases
23%
Disease-free Survival
23%
BRCA1, BRCA2
22%
Retrospective Analysis
21%
Lynch Syndrome
21%
Mutation Carriers
20%
Cancer Patients
20%
Intraperitoneal Chemotherapy
19%
T1N0
19%
Tumor Differentiation
19%
Prognostic Marker
19%
Locally Advanced
19%
Advanced Gastric Adenocarcinoma
19%
Young Patients
18%
Lung Metastasis
18%
Patient Selection
18%
Confidence Interval
18%
Liver Metastasis
18%
Tumor
16%
High Risk
16%
Median Overall Survival
15%
Postoperative Outcomes
14%
Preoperative Chemotherapy
14%
Peritoneal Metastasis
14%
Germline BRCA1/2 mutation
13%
National Cancer Database
13%
Carcinoembryonic Antigen Levels
13%
Pathogenic Variants
13%
Ashkenazi Jews
13%
Hazard Ratio
13%
Pancreatic Cancer
13%
Monotherapy
12%
Prognostic Value
12%
Founder mutation
12%
Intraoperative Radiation Therapy
12%
Israel
11%
Pathological Complete Response
11%
Medicine and Dentistry
Cytoreductive Surgery
94%
Hyperthermic Intraperitoneal Chemotherapy
72%
Overall Survival
59%
Malignant Neoplasm
52%
Intraperitoneal Chemotherapy
47%
Peritoneum Metastasis
43%
Metastatic Carcinoma
40%
Peritoneum Cancer
39%
Adjuvant Chemotherapy
36%
Colorectal Carcinoma
32%
Metastatic Colorectal Cancer
31%
Elderly Patient
29%
Stomach Adenocarcinoma
29%
Diseases
28%
Neoplasm
27%
Disease Free Survival
27%
BRCA1
20%
Recurrent Disease
19%
Tumor Differentiation
19%
Colon Carcinoma
19%
Cancer
18%
Lung Metastasis
18%
Breast Cancer
16%
Hazard Ratio
16%
Pancreas Adenocarcinoma
15%
Preoperative Chemotherapy
15%
Monotherapy
12%
Clinical Trial
12%
Pancreas Cancer
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Lung
11%
DNA Repair
11%
Gene Mutation
11%
Germ Cell
11%
Liver Metastasis
11%
Surgical Margin
11%
Adjuvant Therapy
11%
Oxaliplatin
10%
Gene Repair
9%
Disease Course
9%
Multiple Endocrine Neoplasia Type I
9%
Clinical Stage
9%
Cancer Research
9%
BRCA2
9%
Rectum Carcinoma
9%
Small Intestine Obstruction
9%
Microsatellite Instability
9%
Ras Signaling
9%
Pancreas Islet Cell Tumor
9%
Obstruction
9%